-
Most Popular
Search Results
240 results for icgn
Biotech Speculators Should Try a Small Position in Ocugen Stock
Probably because it’s not a buzzworthy coronavirus stock, you might not hear much about OCGN stock but it still has strong upside potential.
Icon Energy Fund Offers Commodity Focus to IRA Investors
With top oil stocks like Exxon and Chevron, the Icon Energy Fund is a good way to buy the energy sector and the rise in…
OCGN Stock: The COVAXIN News That Has Ocugen Plunging Today
Retail investors refuse to let OCGN stock die, even as the company makes it known that it wouldn’t be applying for a crucial authorization.
The Slide in Ocugen Could Be a Slide to a Homerun
Ocugen has potential for its gene therapy treatment for eye diseases, but OCGN stock movement has been all about Covaxin.
Ocugen Stock Looks Overinflated
Celebrating Ocugen’s value-added collaboration to develop a potentially lifesaving vaccine is fine, but OCGN stock might be too pricey now.
5 Investors Betting Big on Ocugen (OCGN) Stock Right Now
Ocugen has been falling after announcing a new share offering. But that’s not the only reason hedge funds are moving away from OCGN stock.
OCGN Stock: 2 Huge Reasons Ocugen Stock Is Shooting Higher Today
OCGN stock is surging on some big news. The World Health Organization could give the company the go-ahead on its Covid-19 vaccine very soon.
Investor Fears About Covaxin Have Ocugen Shares on Sale
OCGN stock at this point is either an inexpensive Covid-19 vaccine stock, or an over-priced investigational gene therapy stock — or both.
Ocugen Stock Isn’t Pricing In the Hard Road Ahead
OCGN stock has soared thanks to a Covid-19 vaccine partnership. But Ocugen needs time, capital, and competitive success that may not arrive.
OCGN Stock: What Ocugen Investors Are Saying as Shares Surge Today
Ocugen (OCGN) stock is on the move today as traders on social media push the company higher in a new rally for the shares.
OCGN Stock Alert: Why Ocugen Shares Are Drawing Eyes Ahead of Nov. 3
A key WHO ruling that could materialize as soon as tomorrow has investors considering where OCGN stock could be headed this week.
Take Your Ocugen Stock Profits and Run If You Haven’t Already
While OCGN stock produced one of the most remarkable rides in the market, it’s time to get off this train before it derails.
A Couple Of Shots in the Arm for Ocugen Stock
Off and on the price chart, OCGN stock is setting itself up for big things that should have the attention of bullish investors.
Ocugen’s Recent Vaccine Efficacy Results Should Have Traders Cheering
While the Delta variant Covid-19 strain threatens the population, OCGN stock investors can count on Ocugen to advance its vaccine candidate.
Why Is ImmunoGen (IMGN) Stock Up 125% Today?
ImmunoGen (IMGN) stock is rising higher on Wednesday after the company released results from a Phase 3 trial for treating ovarian cancer.
Why Is ImmunoGen (IMGN) Stock Up 81% Today?
ImmunoGen stock is taking off on news that AbbVie is acquiring all outstanding shares of IMGN in a $10.1 billion acquisition deal.
OCGN Stock Falls Ocugen Must Restate Its Financials
After an impressive rally to date, investors appear to be in selling mode with OCGN stock on the news it will need to restate its…
OCGN Stock Alert: Why Is Ocugen Up 20% Today?
With Ocugen receiving a green light to move ahead with a key retinal therapeutic, OCGN stock jumped on the positive implications.
OCGN Stock Alert: Why Is Ocugen Heating Up Today?
Shares of OCGN stock are flying higher after the FDA lifted its clinical hold on Covaxin, the company’s coronavirus drug candidate.
OCGN Stock Alert: Why Is Ocugen Soaring 10% Today?
Shares of OCGN stock are in the green after Covaxin demonstrated strong protection against the omicron and delta variants.
OCGN stock: The Big COVAXIN News Boosting Ocugen Today
Today, OCGN stock is on the move as the company announced its intention to expand its commercialization rights to include Canada.
4 – 10 of 240 results
